“We are delighted to welcome Rob to the eClinical Solutions leadership team,” said Raj Indupuri, CEO of eCS. “His in-depth knowledge and experience in clinical research as a client and end-user of platforms like elluminate will help to accelerate the execution of the elluminate product roadmap."
MANSFIELD, Mass. (PRWEB) January 16, 2020
eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, today announced the appointment of Robert Musterer as the company’s Vice President of Product Management as part of its expansion due to increased demand for the elluminate®️ Clinical Data Hub and technology enabled services. The increase in data sources and the accelerated pace of innovation in the life sciences industry have made formal data strategies, a centralized data hub, data management workbenches and improved analytics more vital than ever in bringing new therapies to market faster. These issues continue to be pressing concerns for life sciences companies. As noted in a recent report by Gartner, Life Science CIOs: Embrace Next-Generation Data and Analytics Platforms to Manage Clinical Data Challenges*, “according to Gartner’s 2019 CIO Survey, 46% of life science CIOs state that BI/data analytics capabilities will receive the largest amount of new or additional investments.”
Highlighted in the Gartner report as an example vendor of an analytics workbench, eClinical Solutions and its powerful elluminate®️ platform are driving improved insight and control over clinical data. The addition of Rob Musterer, a clinical systems expert with over 25 years of experience in clinical programming, biostatistics and data management in large pharmaceutical companies including Bayer Healthcare and Schering-Plough Pharmaceuticals, helps to strengthen the customer and end-user knowledge of the eCS product strategy function.
“We are delighted to welcome Rob to the eClinical Solutions leadership team,” said Raj Indupuri, CEO of eCS. “His in-depth knowledge and experience in clinical research as a client and end-user of platforms like elluminate will help to accelerate the execution of the elluminate product roadmap.”
Rob most recently served as the President of ER Squared, a consultancy helping life sciences companies of all sizes to establish successful data strategies and to identify the best fit technology infrastructure and implementation processes. “I worked with numerous clients across the industry and consistently heard about their challenges managing and accessing more sources and types of external data and finding better ways to conduct automated and comprehensive data review. I joined eCS as the elluminate platform meets these needs and more. It also presents a unique opportunity to automate currently manual processes like data mapping and data review with AI/ML capabilities resulting in dramatic time, cost, and quality improvements in clinical development.”
Additionally, eCS has doubled their Boston-area headquarters with almost 12,000 square feet of new office space. In the last three years, the company has grown significantly year-over-year and expects to aggressively hire new team members in the U.S. in 2020. eClinical Solutions also recently expanded into the European market adding new team members in the U.K.
*Gartner, Life Science CIOs: Embrace Next-Generation Data and Analytics Platforms to Manage Clinical Data Challenges, Jeff Smith, 22 October 2019
About eClinical Solutions LLC
eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies. For more information, visit http://www.eclinicalsol.com.